Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation. Neither IGC,
the medical associations, nor the authors endorse any product or service associated with the
distributor of this clinical reference tool.
Source
Aronson N et al. , Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines
by e Infectious Diseases Society Of America (IDSA) and the American Society of
Tropical Medicine and Hygiene (ASTMH) [remainder of citation pending publication]
Abbreviations
BUN, blood urea nitrogen; CBC, complete blood count; CDC, Centers for Disease
Control and Prevention; CL, cutaneous leishmaniasis; CPK, creatine phosphokinase;
D5W, 5% dextrose in water; DAT, direct agglutination test; DoD, Department
of Defense; ECG, electrocardiogram; ELISA, enzyme-linked immunosorbent
assay; EMLA, lidocaine and prilocaine topical anesthetic; FDA, Food and Drug
Administration; GI, gastrointestinal; IL, intralesional; IM, intramuscular; IND,
Investigational New Drug ; IV, intravenous; kg, kilogram; MBCL, methylbenzethonium
chloride; mg, milligram; mL, milliliter; ML, mucosal leishmaniasis; mm, millimeter;
PCR, polymerase chain reaction; PO, by mouth; QTc, corrected QT interval (on ECG);
rK39, recombinant K39 antigen; Recs, recommendations; SbV, pentavalent antimony;
sec, second(s); US, United States; VL, visceral leishmaniasis
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2016 All rights reserved
IDSALEI16123
